European Medicines Agency
Latest News
-
EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma
— May 25 2012 2:46 PM from News-Medical.net -
Pfizer (PFE): European Committee Adopts Positive Opinion For Kidney Cancer Treatment
— May 25 2012 1:44 PM from iStockAnalyst -
Pfizer's Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU
— May 25 2012 1:31 PM from iStockAnalyst -
Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU
— May 25 2012 1:17 PM from Street Insider -
Pfizer (PFE) Axitinib Gets Positive Opinion from CHMP EMA
— May 25 2012 1:14 PM from Street Insider
